Insights into the relationship between nasal bacterial composition and susceptibility to early-life respiratory disease: a pilot observational study.

This pilot observational study suggests that distinct nasal bacterial endotypes, particularly those dominated by *Moraxella* or *Streptococcus*, may influence early-life wheezing outcomes in a sex-dependent manner, highlighting the potential of the nasal microbiota as a target for predicting and preventing respiratory infections.

The Gist

Imagine a baby's nose as a busy, bustling garden. In this garden, tiny plants (bacteria) grow alongside the air we breathe. For a long time, scientists have wondered: Does the type of garden a baby has affect how often they get sick with coughs, colds, or wheezing?

This paper is a "pilot study," which is like a small-scale test run to see if the idea is worth investigating further. Here is what the researchers found, explained simply:

1. The Two Main Types of "Gardens" (Endotypes)

The researchers looked at 90 nose swabs from 55 babies. They discovered that the bacterial gardens in these babies generally fell into two main categories, or "endotypes":

• The "Moraxella" Garden: This garden is dominated by a specific type of bacteria called Moraxella. It's like a garden where one type of plant takes up most of the space.
• The "Streptococcus" Garden: This garden is dominated by Streptococcus bacteria. Interestingly, this garden had more variety (more different types of plants) than the Moraxella garden.

2. What Happens When a Virus Arrives?

When a baby gets a cold, a virus (like a storm) blows into the garden. The researchers wanted to see if the storm changed the garden.

• The Storm Effect: When babies were sick, their gardens became slightly less diverse (fewer types of plants), but the total number of plants didn't change.
• The Rhinovirus Connection: When the "Rhinovirus" (a common cold virus) was present, it seemed to team up with the Moraxella bacteria. It was like the storm and the Moraxella plants dancing together. However, when the "SARS-CoV-2" virus was present, it didn't seem to have a special dance with any specific bacteria.

3. The Big Discovery: Who Gets Wheezy?

The most interesting part of the study was looking at which babies developed wheezing (a whistling sound when breathing) in their first year of life.

• The Pattern: Babies with the Moraxella-dominated garden tended to start wheezing earlier and had more episodes of wheezing.
• The Protection: Babies with the Streptococcus-dominated garden (the more diverse one) tended to start wheezing later and had fewer episodes.
• The Gender Twist: This pattern was very clear in girls. Girls with the Moraxella garden wheezed much more often than girls with the Streptococcus garden. For boys, the difference wasn't as clear in this small group.

4. Important Caveats (The "Fine Print")

The authors are very careful to say this is just a pilot study. Think of it as a scout looking for a path before the main army arrives.

• Small Sample Size: They only looked at 55 babies.
• One Outlier: One girl in the Moraxella group had a lot of wheezing episodes (14 times!). If you remove her from the data, the connection between the bacteria and wheezing becomes less obvious. This means the results are sensitive and need to be checked again with more babies.
• No Proof Yet: They are not saying that changing a baby's nose bacteria will cure or prevent wheezing. They are simply saying, "We found a link that looks interesting and needs more testing."

The Bottom Line

This study suggests that the "flora" (bacteria) in a baby's nose might act like a unique fingerprint that hints at how likely they are to get wheezy, especially for girls. The "Moraxella" garden seems to be a riskier neighborhood for early wheezing, while the "Streptococcus" garden seems safer. However, because this was a small test, scientists need to run a much larger study to confirm if this rule holds true for everyone.

Technical Summary

1. Problem Statement

Early-life susceptibility to viral respiratory infections is a critical predictor of long-term respiratory morbidity, including recurrent wheezing and asthma. Despite the high burden of these conditions, particularly in vulnerable populations, there are no clinically validated biomarkers to predict which infants will develop severe or persistent respiratory disease. While the nasopharyngeal microbiota has been linked to respiratory health, previous studies often relied on partial 16S rRNA gene sequencing, which lacks the taxonomic resolution to distinguish species-level differences. Furthermore, it remains unclear how specific nasal (anterior nares) microbial communities, which are the frontline of viral exposure, interact with respiratory viruses and influence clinical outcomes like wheezing.

2. Methodology

This study utilized a pilot substudy design nested within the AERIAL birth cohort (Airway Epithelium Respiratory Illnesses and Allergy), which is part of the larger ORIGINS project in Western Australia.

• Cohort & Sampling: The study analyzed 90 nasal swabs from 55 infants (30 female, 25 male). Samples included:
  • Asymptomatic: Scheduled visits at ~3, 6, and 9 months of age ($n=42$).
  • Symptomatic: Collected during respiratory illness episodes via a smartphone app ($n=48$).
  • Paired Data: 33 infants had both an asymptomatic baseline and a subsequent symptomatic sample.
• Sequencing & Profiling:
  • Technique: Full-length 16S rRNA gene sequencing using the PacBio Sequel IIe platform to achieve high species-level resolution.
  • Processing: Reads were processed using DADA2 (v1.28.0) and the GTDB (vR09-RS220) reference database.
  • Quality Control: Rigorous decontamination was performed using the decontam R package based on negative extraction controls and bacterial load quantification (pan-bacterial TaqMan assay).
• Viral Detection: A separate swab from each collection was tested via qPCR for a respiratory virus panel.
• Statistical Analysis:
  • Community Structure: Analyzed using PERMANOVA on Aitchison distances and Dirichlet Multinomial Mixtures (DMM) to identify microbial endotypes.
  • Diversity & Abundance: Alpha diversity (Shannon index), bacterial load, and differential abundance (ANCOM-BC2) were calculated.
  • Associations: Negative binomial regression and linear models were used to correlate microbial endotypes with wheezing frequency and onset age, adjusting for sex and other covariates.

3. Key Contributions

• High-Resolution Taxonomy: The study is one of the first to apply full-length 16S rRNA sequencing to infant nasal microbiomes, allowing for precise species-level identification (e.g., distinguishing Moraxella nonliquefaciens from M. catarrhalis) rather than genus-level approximations.
• Endotype Identification: The application of probabilistic modeling (DMM) successfully identified two distinct, stable nasal microbial endotypes in infancy, moving beyond simple taxonomic lists to functional community types.
• Virus-Bacteria Specificity: The study elucidates that viral-bacterial interactions are virus-specific, showing distinct patterns for Rhinovirus versus SARS-CoV-2.
• Sex-Stratified Analysis: It highlights a potential sex-dependent mechanism where nasal microbiota endotypes differentially predict wheezing outcomes in females versus males.

4. Key Results

Microbial Composition and Diversity

• Dominant Taxa: The nasal microbiome was dominated by Moraxella (specifically M. nonliquefaciens and M. catarrhalis) and Streptococcus species.
• Symptomatic vs. Asymptomatic: Overall community composition did not differ significantly between asymptomatic and symptomatic groups across the cohort. However, paired longitudinal analysis revealed that alpha diversity decreased significantly during symptomatic episodes compared to the same infant's asymptomatic baseline.
• Bacterial Load: Bacterial load remained stable regardless of symptom status or viral presence.

Virus-Bacteria Interactions

• Rhinovirus (RHV): RHV-positive symptomatic swabs showed:
  • Lower alpha diversity compared to SARS-CoV-2 positive swabs.
  • Significant enrichment of Moraxella catarrhalis (7.44-fold increase).
  • Negative correlation with Streptococcus abundance.
• SARS-CoV-2: No significant correlations were found between SARS-CoV-2 detection and specific bacterial taxa or diversity shifts.

Microbial Endotypes and Clinical Outcomes

Two distinct endotypes were identified:

1. Endotype 1 (Moraxella-dominated): Characterized by M. nonliquefaciens, M. catarrhalis, Streptococcus, and Corynebacterium pseudodiphtheriticum. Lower alpha diversity.
2. Endotype 2 (Streptococcus-dominated): Primarily defined by Streptococcus genus. Higher alpha diversity.

Clinical Associations:

• Wheeze Onset: Infants in Endotype 2 had a significantly later onset of wheeze (approx. 3 months later) compared to Endotype 1.
• Wheeze Frequency:
  • Overall: Endotype 2 showed a trend toward fewer wheezing episodes (IRR = 0.52), though not statistically significant in the unstratified model.
  • Sex-Specific Effect: A strong sex-dependent pattern emerged. In females, Endotype 2 (Streptococcus-dominated) was associated with a 79% reduction in wheezing episodes compared to Endotype 1 (IRR = 0.21, p=0.026). This association was not observed in males.
• Stability: Endotype 1 (Moraxella-dominated) appeared highly stable; no infants transitioned from Endotype 1 to Endotype 2 during symptomatic episodes, whereas transitions from Endotype 2 to Endotype 1 were observed.

5. Significance and Limitations

Significance:
The study suggests that the nasal microbiota is a potential biomarker for early-life respiratory risk. Specifically, a Moraxella-dominated, low-diversity nasal community may predispose infants (particularly females) to earlier and more frequent wheezing. The identification of virus-specific bacterial interactions (Rhinovirus-Moraxella) offers new targets for understanding pathogenesis. These findings support the development of microbiome-based risk stratification tools.

Limitations:

• Pilot Scale: The small sample size ($N=55$) limits statistical power and generalizability.
• Sensitivity to Outliers: The sex-specific findings were sensitive to a single influential data point (a female with 14 wheezing episodes), necessitating validation in larger cohorts.
• Temporal Resolution: Only two time points per infant were analyzed, limiting the ability to map complex longitudinal transitions.
• Functional Gap: 16S rRNA sequencing provides taxonomic data but does not reveal functional mechanisms or gene expression of the microbiome-virus interactions.
• Context: The study occurred during altered viral circulation patterns post-COVID-19 public health measures.

Conclusion:
This pilot study provides proof-of-concept that distinct nasal bacterial endotypes exist in infancy and are associated with wheezing phenotypes in a sex-dependent manner. Future large-scale longitudinal studies are required to validate these endotypes as predictive biomarkers for respiratory disease susceptibility.